Letrox (Levothyroxine Sodium, Hydrate)

After oral absorption, levothyroxine sodium hydrate is converted to the active hormone triiodothyronine (T3). T3 binds nuclear thyroid receptors, influencing gene expression that controls metabolism, growth, and development, thereby correcting hormone deficiency.

The appropriate dose of Letrox is individualized. A qualified prescriber determines the exact amount based on the patient’s age, weight, thyroid function tests, and clinical response, and may adjust it over time.

Levothyroxine is classified as a pregnancy‑category drug that may be used when clearly needed. The prescriber evaluates risks and benefits for both mother and fetus. Breastfeeding is generally considered compatible, but monitoring of infant thyroid status may be advised.

To order Letrox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Letrox provides levothyroxine sodium hydrate, the same active ingredient found in other synthetic T4 preparations. Differences among products are usually related to formulation, bioavailability, and regulatory approvals. Clinical efficacy is comparable when dosing is appropriately adjusted.

Letrox should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight, and excessive heat to maintain potency.

Letrox is taken orally, usually on an empty stomach 30‑60 minutes before breakfast. The tablet should be swallowed whole with a glass of water and not crushed or chewed.

Serious risks include cardiac arrhythmias, angina, and severe allergic reactions such as anaphylaxis. Over‑replacement can lead to hyperthyroid symptoms, which may precipitate heart problems, especially in patients with pre‑existing cardiac disease.

Letrox is contraindicated in patients with untreated adrenal insufficiency, acute myocardial infarction, or known hypersensitivity to levothyroxine or any excipients. It should also be avoided in individuals who are not thyroid‑deficient without medical supervision.